RecallDepth

MicroVue CIC-C1q EIA, Model A001. The MicroVue CIC-C1q EIA is for detection of circulating immune complexes (CIC) in human serum or plasma. The MicroVue CIC-C1q EIA is for detection of circulating immune complexes (CIC) in human serum or plasma. In certain disease states, immune complexes may initiate complement mediated damage of various organs and tissues. This activation of complement may begin a series of potentially destructive events including cell lysis, the production of anaphylatoxins, leukocyte stimulation and activation of macrophages. Major tissue damage can also occur when CIC fix to cell membranes as in some cases of glomerulonephritiscirculating immune complexes (CIC) in human serum or plasma.

This recall has been terminated (originally issued November 3, 2015).

Company
Diagnostic Hybrids, Inc.
Recall Initiated
November 3, 2015
Terminated
August 28, 2020
Recall Number
Z-1497-2018
Quantity
19 kits
Firm Location
Athens, OH
Official Source
View on FDA website ↗

Reason for Recall

A component of the kit was found to contain bacterial contamination.

Distribution

Worldwide Distribution - USA (nationwide) to the states of : CO, CT, IA, IL, MN, MO, NC, NY, OH TX, and UT., and to the countries of : Switzerland, India, Hong Kong, and Japan.

Lot / Code Info

Lot 051076

Root Cause

Material/Component Contamination

Action Taken

Customers were notified via letter dated November 3, 2015, to review their inventory for the specified lots, discard the kits, and contact the recalling firm for replacement. Certificates of destruction were also provided to customers. For further questions, please call (740) 589-3300.

More recalls by Diagnostic Hybrids, Inc.

View all recalls by this company →